Date: 2009-05-04
Description: Approvals for several first-in-class kinase inhibitors have resulted in a wider recognition of kinases as an important class of target. Although a relatively young market, 173 kinase-related genes are now being targeted in drug developments.
Date: 2010-05-06
Description: Consumer time pressure and demand for higher quality continue to drive growth in ready meals. Meanwhile, private label developments, new sales channels such as independent ready meal stores and internet based delivery services are driving innovation.
Date: 2011-03-30
Name(s): Raithatha, Carol
Description: This report analyzes the future of salt reduction, assesses existing and future technologies and ingredients to reduce sodium content and provides company analysis and product examples of salt reduced, low salt and no-salt brands.
Date: 2010-05-28
Description: The global soft drinks market was worth $479bn in 2009. In Western Europe and the US, the soft drinks market is fairly mature and driven by added value products, but emerging markets such as Russia, China, Brazil and Mexico will see high growth.
Date: 2010-04-14
Description: Growth in the global spirits market is beginning to slow and is even declining in some categories. Market consolidation, maturity, private label and health concerns are driving this stagnation.
Date: 2011-01-12
Name(s): Barton, Cheryl L.
Description: The market for cancer therapies is the fastest growing segment of the pharmaceutical market driven by high levels of unmet clinical need. Innovative delivery technologies will drive even faster growth by increasing the efficacy of cancer therapy.
Date: 2011-11-09
Description: Global markets for percutaneous transluminal angioplasty and transcatheter aortic valve implantation devices will be driven by expanding disease populations and growth in emerging markets.
Date: 2011-11-08
Name(s): Doorbar, Lucy
Description: The wound care market is a fast moving and constantly changing sector of the medical device market and the recent emergence of biologics within the wound care sector is anticipated to have a significant impact.
Date: 2008-05-15
Name(s): Barton, Cheryl L.
Description: The cost of developing drugs has risen dramatically and fewer drugs are obtaining regulatory approval. The pharmaceutical industry is seekingways to improve drug development and one area of focus is adaptive clinical trial design.
Date: 2010-12-13
Name(s): Lansdell, Mark
Description: This report assesses and documents the innovative drug discovery taking place in a corporate setting in countries that constitute emerging pharmaceutical markets (Brazil, Mexico, China, India, and Russia).
Date: 2009-05-19
Name(s): Humphries, Gavin
Description: The fastest-growing medium has been the Internet, with rapidly increasing numbers of people worldwide going online. In western Europe and North America there have also been large rises in the amount of time spent online.
Date: 2008-08-26
Name(s): Barton, Cheryl L.
Description: Many pharma companies are currently engaged in wide-scale R&D restructuring, adopting a biotechnological approach to drug development by establishing disease-focused R&D units, R&D spin-offs, strategic partnerships and joint ventures.
Date: 2008-12-01
Name(s): Zhang, Jim
Description: The pharma outsourcing industry in China has experienced over 35% year on year growth in the past few years. Increasingly, the sophisticated service offer of multinational CROs/CMOs is being challenged by improving Chinese players.
Date: 2010-12-14
Name(s): Doxey, Mark
Description: Pharmaceutical sales in emerging markets have been expanding rapidly in recent years, and are likely to account for a significant share of global pharma industry growth over the next 5 years. However, concerns remain about the lack of IP protection.
